Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of August 10, 2026.
NPIDirectory

Charles John Puza

Individual provider Dermatology Physician · NPI 1295294189

Charles John Puza practises Dermatology in New York, New York. Graduated from Duke University School of Medicine in 2019, 7 years ago. Practices with David a Colbert MD PC, a 6-clinician group and accepts Medicare assignment. Licensed in New York.

Years since qualifying
7
Trained at
Duke University School of Medicine
Licensed in
NY
In the registry since
2019
Claim this listing Report a problem Suggest an edit

Practice location Address checks out

119 5th Ave
New York, NY 10003-0068
Phone: (212) 533-8888
Show map & directions

Directions in Google Maps · Apple Maps · OpenStreetMap

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Specialties & licences

Dermatology Physician (primary) Taxonomy 207N00000X · Licence 322183 (NY)

Record details

NPI number1295294189
Entity typeIndividual (Type 1)
GenderMale
Sole proprietorNo
NPI enumeratedMarch 19, 2019
Last updated in NPPESJune 12, 2025
Certification dateJune 12, 2025

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyDERMATOLOGY
Medical schoolDUKE UNIVERSITY SCHOOL OF MEDICINE
Graduated 2019 (7 years in practice)
Group practice David A Colbert Md Pc — 6 clinicians
Accepts Medicare assignment Yes — accepts the Medicare-approved amount

Procedures

From CMS Care Compare, which counts the procedures a clinician billed to Original Medicare and Medicare Advantage over a recent 12-month period. CMS reports a fixed list of common procedures, so this is not everything the clinician does. Counts of 10 or fewer are given as a range, because CMS withholds small numbers.

Removal of skin lesions 38 times · 70th percentile
Skin biopsy 11 times · 59th percentile
Removal or shaving of skin growth 1–10 times

The percentile compares how often this clinician performed the procedure with other clinicians who performed it, as CMS calculates it. It measures volume, not outcomes or skill.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $203 11 payments · a meal or drink at a meeting or visit, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Colleagues at David a Colbert MD PC

Clinicians the CMS Doctors & Clinicians file lists under the same group practice.

Other providers in New York